Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongxinshu Capsule for stable angina in coronary heart disease
ChiCTR2000039731Phase 4Recruiting
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Tongxinshu capsule in coronary arteriosclerosis and stable angina (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Seattle Angina Questionnaire score. Started Jan 2020; status: recruiting.
02
Drugs
Tongxinshu capsule
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR2000039731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039731.